Mind over migraine: Disease burden, innovative therapies, and managed care trends in treating migraine disease
- PMID: 40577027
- PMCID: PMC12204328
- DOI: 10.18553/jmcp.2025.31.7-a.s1
Mind over migraine: Disease burden, innovative therapies, and managed care trends in treating migraine disease
Abstract
Migraine is a genetically influenced complex neurological disease characterized by attacks of moderate to severe headaches and a variety of concomitant symptoms. Migraine disease can significantly impact individuals' daily activities and quality of life. It is a major cause of disability and loss of productivity, which can be exacerbated by migraine-related stigma. Recent advances in migraine treatment and ongoing research may offer additional options for patients; however, treatment barriers still exist, resulting in underdiagnosis and undertreatment of migraine disease, especially in some minority and vulnerable groups. Primary care and emergency department providers are often the first point of contact for patients with migraine disease, so there is opportunity for them to assist in addressing these barriers, particularly with strategies to make care more patient-centered. Managed care organizations can also play a role in overcoming these barriers and supporting equitable access.
Conflict of interest statement
This supplement was written by Bridget Flavin, PharmD, CMPP, Founder, Connected Content, Ltd. Connected Content, Ltd., received payment from AMCP for the preparation of this manuscript. Flavin is also an adjunct associate professor at the University of Florida College of Pharmacy and reports stock in Elevance Health. AMCP conceptualized this supplement, and funding was provided by an independent medical education grant from Pfizer, Inc. Pfizer, Inc., manufactures Zavzpret (zavegepant) and Nurtec ODT (rimgepant).
Figures
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
Non-pharmacological interventions for prophylaxis of vestibular migraine.Cochrane Database Syst Rev. 2023 Apr 12;4(4):CD015321. doi: 10.1002/14651858.CD015321.pub2. Cochrane Database Syst Rev. 2023. PMID: 37042522 Free PMC article.
-
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159. Health Soc Care Deliv Res. 2025. PMID: 40548558
-
Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.Health Technol Assess. 2024 Oct;28(63):1-329. doi: 10.3310/AYWA5297. Health Technol Assess. 2024. PMID: 39365169 Free PMC article.
References
-
- Pescador Ruschel MA, De Jesus O. Migraine Headache. Updated July 5, 2024. In: StatPearls. [Internet] StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK560787/ - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical